AngioGenex, Inc.
Pharmaceutical company · New York, United States
AngioGenex, Inc. is a pharmaceutical company headquartered in New York, United States. It has received 1 US government small-business research award (SBIR/STTR) from health agencies, $163,150 in total, most recently in 2010. It has reported private securities offerings to the US SEC, most recently $260,000 sold in a notice filed in 2021.
AngioGenex at a glance
What does AngioGenex do?
US government research funding
1 SBIR/STTR small-business research award from US health agencies, $163,150 in total (2010).
Private fundraising reported to the SEC
2 Form D notices; the most recent reported $260,000 sold (2021).
Frequently asked questions about AngioGenex
Where is AngioGenex headquartered?
AngioGenex, Inc. is headquartered in New York, United States.
What does AngioGenex do?
AngioGenex, Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
Similar companies
- SchrodingerNew York City, New York, United States
- Pfizer IncNew York City, New York, United States
- Actinium Pharmaceuticals, Inc.New York City, New York, United States
- Rocket Pharmaceuticals, Inc.New York City, New York, United States
- Progenics Pharmaceuticals IncNew York City, New York, United States
- Syndax Pharmaceuticals IncNew York City, New York, United States
- Nuvation Bio Inc.New York City, New York, United States
- Immunic, Inc.New York City, New York, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-25. Data licences